- Home
- MBRX vs NCRA Comparison
MBRX vs NCRA Comparison
Compare MBRX & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- NCRA
- Stock Information
- Founded
- MBRX 2015
- NCRA 2002
- Country
- MBRX United States
- NCRA Taiwan
- Employees
- MBRX N/A
- NCRA N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- NCRA Farming/Seeds/Milling
- Sector
- MBRX Health Care
- NCRA Consumer Staples
- Exchange
- MBRX Nasdaq
- NCRA Nasdaq
- Market Cap
- MBRX 17.1M
- NCRA 15.1M
- IPO Year
- MBRX 2016
- NCRA N/A
- Fundamental
- Price
- MBRX $0.38
- NCRA $1.58
- Analyst Decision
- MBRX Strong Buy
- NCRA
- Analyst Count
- MBRX 4
- NCRA 0
- Target Price
- MBRX $5.00
- NCRA N/A
- AVG Volume (30 Days)
- MBRX 4.0M
- NCRA 19.2K
- Earning Date
- MBRX 11-07-2025
- NCRA 08-14-2025
- Dividend Yield
- MBRX N/A
- NCRA N/A
- EPS Growth
- MBRX N/A
- NCRA N/A
- EPS
- MBRX N/A
- NCRA N/A
- Revenue
- MBRX N/A
- NCRA $13,865,984.00
- Revenue This Year
- MBRX N/A
- NCRA N/A
- Revenue Next Year
- MBRX N/A
- NCRA N/A
- P/E Ratio
- MBRX N/A
- NCRA N/A
- Revenue Growth
- MBRX N/A
- NCRA N/A
- 52 Week Low
- MBRX $0.25
- NCRA $0.70
- 52 Week High
- MBRX $3.65
- NCRA $2.09
- Technical
- Relative Strength Index (RSI)
- MBRX 32.94
- NCRA 55.34
- Support Level
- MBRX $0.35
- NCRA $1.45
- Resistance Level
- MBRX $0.62
- NCRA $1.58
- Average True Range (ATR)
- MBRX 0.05
- NCRA 0.09
- MACD
- MBRX -0.02
- NCRA -0.02
- Stochastic Oscillator
- MBRX 8.19
- NCRA 65.84
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.